Communication, Dissemination and Exploitation Plan
(s’ouvre dans une nouvelle fenêtre)
All dissemination activities will be systematically reported through a periodic report to the EU Commission for traceability. In every dissemination and outreach activity, MSCA-EF funding will be acknowledged. The ECR’s current membership in ESB will be used as an effective tool to gain wider audiences. Social media platforms will allow wider dissemination to the clinical and non-clinical research communities. The ECR is connected to various experts (Neurosurgeons, Radiologists, Biomedical Engineers, and Professors) using LinkedIn (1400 followers and 7000 views per post) around the globe. It can be an effective tool for dissemination to a wider audience at reduced efforts. The ECR will share the research experiences by writing blogs in European Stroke Organization and in host institute media coverage in consultation with the Public Relation (PR) office. The ECR and supervisor will try to follow this path and make the research as reachable to broad audiences as possible. On a personal level, the ECR will try to share the acquired knowledge during this fellowship using a personal webpage and ResearchGate profile by writing blogs and short articles. The ECR will attend international conferences, webinars, workshops, and summer schools for dissemination. The ECR will showcase VThrombectomy results to industries such as CERENOVUS Stroke Solutions, Abbott, and Medtronic from host institute links to the industry office. Such showcase and link with the industry will help to deliver the fellowship output into a valuable product at a reduced cost. The coalition between industry & host institute will open new doors for further funding and valuable product development collaboratively. The host lab can be benefitted from the developed infrastructure during fellowship for their upcoming graduate student and elevate it to the next level. VThrombectomy will benefit the 1.12 million people in EU suffering from stroke. The expected outcomes are improved stent retriever designs and optimised treatment parameters to reduce post-treatment complications. It will benefit various global research groups working on EVT improvement & collaboration.
